FibroGen Inc (FGEN)
0.4986
+0.02
(+3.88%)
USD |
NASDAQ |
Dec 24, 16:00
FibroGen Free Cash Flow: -126.23M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biomarin Pharmaceutical Inc | 300.88M |
| Arbutus Biopharma Corp | -71.92M |
| GlycoMimetics Inc | -35.02M |
| Cidara Therapeutics Inc | -160.15M |
| Cue Biopharma Inc | -38.32M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.376M |
| Cash from Investing (Quarterly) | 0.755M |
| Cash from Financing (Quarterly) | -0.127M |
| Free Cash Flow Per Share (Quarterly) | -0.0841 |
| Free Cash Flow to Equity (Quarterly) | -8.759M |
| Free Cash Flow to Firm (Quarterly) | -7.265M |
| Free Cash Flow Yield | -254.5% |